A comprehensive view of Phase 1 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Three-year follow-up data from Phase 1 trial of BioNTech and Genentech's mRNA cancer vaccine candidate autogene cevumeran show effective T cell responses and delayed tumor recurrence in patients with resected pancreatic ductal adenocarcinoma
Published: April 07, 2024 by BioNTech SE
Moderna reports its investigational injectable mRNA therapy mRNA-3927 shows potential clinical benefits and infrequent side effects in phase 1/2 study; therapy is aimed at treating inherited metabolic disorder propionic acidemia
Published: April 03, 2024 by Moderna Inc.
ClinicalTrials.gov registers Phase 1 trial for inactivated Zika virus vaccine VLA1601 in healthy adults; trial includes testing of three antigen dose levels and two adjuvants in combination with the vaccine candidate
Published: March 29, 2024 by Health Daily Digest
GlaxoSmithKline initiates Phase 1 clinical trial for study of tsr-022, an anti-tim-3 monoclonal antibody, in patients with advanced solid tumors; trial to involve 475 participants from the US
Published: March 22, 2024 by Contify Life Science News
Boehringer Ingelheim partners with Shanghai RAAS for the development and clinical production of hemophilia drug SR604 injection; the drug has received approval for Phase I clinical trial targeting hemophilia and congenital factor VII deficiency
Published: March 21, 2024 by Contify Life Science News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count